Horizon Discovery has launched the first products and services for its new GENASSIST range of gene editing kits and reagents that are designed to enable easier implementation of CRISPR and rAAV gene editing experiments.   The current GENASSIST offering includes off-the-shelf reagents for using CRISPR editing technology and a kit combination of these reagents to allow customers to generate their own CRISPR-ready cell lines that express Cas9-nickase. According to the company, using such cell lines...